Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151

Results For "Drug"

3152 News Found

AstraZeneca receives CDSCO approval for Tremelimumab combination in India
Drug Approval | June 02, 2023

AstraZeneca receives CDSCO approval for Tremelimumab combination in India

Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)


Evonik launches next-generation peptide for biopharma applications
News | June 02, 2023

Evonik launches next-generation peptide for biopharma applications

One thousand times more soluble than L-cystine at neutral pH


Lupin receives USFDA approval from Obeticholic Acid Tablets
Drug Approval | June 01, 2023

Lupin receives USFDA approval from Obeticholic Acid Tablets

Obeticholic Acid Tablets had estimated annual sales of US$ 262 million in the U.S. (IQVIA MAT Mar 2023).


Honeywell refurbishes PHCs in rural India across three states
Healthcare | June 01, 2023

Honeywell refurbishes PHCs in rural India across three states

The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana


HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally
News | June 01, 2023

HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally

HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date


Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData
News | May 31, 2023

Janssen Tremfya excels as psoriasis treatment, outshining IL-17s, says GlobalData

The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab


Concept Medical gets 4th IDE approval from USFDA
Drug Approval | May 31, 2023

Concept Medical gets 4th IDE approval from USFDA

For the treatment of Superficial Femoral Artery


PharmaLytica returns to Hyderabad
News | May 31, 2023

PharmaLytica returns to Hyderabad

With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South


We need to focus on quality and affordable manufacturing: Mandaviya
Policy | May 29, 2023

We need to focus on quality and affordable manufacturing: Mandaviya

Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities